Skip to main content
Julio Delgado

Julio Delgado, MD, MS

Languages spoken: English, Spanish

Clinical Locations

ARUP

  • Dr. Delgado is the Executive Vice President at ARUP Laboratories, as well as Vice Chair, Department of Pathology at University of Utah School. He is a Professor of Pathology at the University of Utah School of Medicine. He is board certified in clinical pathology and histocompatibility laboratory testing by the American Board of Pathology and the American Board of Histocompatibility and Immunogenetics.

    Specialties

    • Pathology, Clinical

    Board Certification

    American Board of Histocompatibility
    American Board of Pathology (Clinical Path)
  • Dr. Delgado is the Executive Vice President at ARUP Laboratories, as well as Vice Chair, Department of Pathology at University of Utah School. He is a Professor of Pathology at the University of Utah School of Medicine. He is board certified in clinical pathology and histocompatibility laboratory testing by the American Board of Pathology and the American Board of Histocompatibility and Immunogenetics.

    Board Certification and Academic Information

    Academic Departments Parks, Recreation, & Tourism -Primary
    Board Certification
    American Board of Histocompatibility
    American Board of Pathology (Clinical Path)

    Education history

    Graduate Training Epidemiology - Harvard School of Public Health M.S.
    Immunology Research - CBR Institute for Biomedical Research Postdoctoral Training
    Chief Resident Pathology - Brigham and Women's Hospital Chief Resident
    Pathology - Harvard Medical School Fellow
    Postdoctoral Fellowship Immunogenetics - Dana-Farber Cancer Institute Postdoctoral Fellow
    Medicine - Universidad Industrial de Santander M.D.

    Selected Publications

    Journal Article

    1. Ravkov EV, Williams ESCP, Elgort M, Barker AP, Planelles V, Spivak AM, Delgado JC, Lin L, Hanley TM (2024). Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients. Front Immunol, 14, 1329026. (Read full article)
    2. Jain D, Pido MTJ, Delgado JC, Willrich MAV, Lzr-Molnr E (2023). Comparison of Two Clinical Laboratory Assays for Measuring Serum Adalimumab and Antibodies to Adalimumab. J Appl Lab Med, 8(6), 1054-1064. (Read full article)
    3. Hartsell JD, Leung DT, Zhang Y, Delgado JC, Alder SC, Samore MH (2023). Sex difference in the discordance between Abbott Architect and EuroImmun serological assays. PeerJ, 11, e15247. (Read full article)
    4. Kim SJ, Yao Z, Marsh MC, Eckert DM, Kay MS, Lyakisheva A, Pasic M, Bansal A, Birnboim C, Jha P, Galipeau Y, Langlois MA, Delgado JC, Elgort MG, Campbell RA, Middleton EA, Stagljar I, Owen SC (2022). Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies. Nat Commun, 13(1), 3716. (Read full article)
    5. Nelson HA, Genzen JR, Delgado JC, Rudolf JW (2021). An Interference in an Automated HCO3- Assay Leads to an Unexpected IgG Monoclonal Gammopathy Diagnosis. J Appl Lab Med, 7, 622-625. (Read full article)
    6. Nandakumar V, Profaizer T, Lozier BK, Elgort MG, Rychert J, Slev PR, Delgado JC (2021). Evaluation of a Novel Multiplex Platform for Simultaneous Detection of IgG Antibodies against the Four Main SARS-CoV-2 Antigens. J Appl Lab Med, 7(3), 698-710. (Read full article)
    7. Samore MH, Looney A, Orleans B, Greene T, Seegert N, Delgado JC, Presson A, Zhang C, Ying J, Zhang Y, Shen J, Slev P, Gaulin M, Yang MJ, Pavia AT, Alder SC (2021). Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA. Emerg Infect Dis, 27(11), 2786-2794. (Read full article)
    8. Nandakumar V, Profaizer T, Lozier BK, Elgort MG, Larragoite ET, Williams ESCP, Solis-Leal A, Lopez JB, Berges BK, Planelles V, Rychert J, Slev PR, Delgado JC (2021). Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays. Arch Pathol Lab Med, 145(10), 1212-1220. (Read full article)
    9. Profaizer T, Dibb K, Bethers H, Monds C, Andreasen J, Delgado JC, Lzr-Molnr E (2020). Comparison of Next-Generation Sequencing-Based Human Leukocyte Antigen Typing with Clinical Flow Cytometry and Allele-Specific PCR Melting Assays for HLA-B27 Genotyping. J Appl Lab Med, 6(5), 1221-1227. (Read full article)
    10. Rychert J, Couturier MR, Elgort M, Lozier BK, Laulu S, Genzen JR, Straseski JA, Delgado JC, Slev PR (2020). Evaluation of 3 SARS-CoV-2 IgG Antibody Assays and Correlation with Neutralizing Antibodies. J Appl Lab Med, 6(3), 614-624. (Read full article)
    11. Zheng Y, Larragoite ET, Williams ESCP, Lama J, Cisneros I, Delgado JC, Slev P, Rychert J, Innis EA, Coiras M, Rondina MT, Spivak AM, Planelles V (2021). Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions. Virol J, 18(1), 1. (Read full article)
    12. Greene DN, Jackson ML, Hillyard DR, Delgado JC, Schmidt RL (2020). Decreasing median age of COVID-19 cases in the United States-Changing epidemiology or changing surveillance? PLoS One, 15(10), e0240783. (Read full article)
    13. Profaizer T, Pole A, Monds C, Delgado JC, Lzr-Molnr E (2020). Clinical utility of next generation sequencing based HLA typing for disease association and pharmacogenetic testing. Hum Immunol, 81(7), 354-360. (Read full article)
    14. Rychert J, Delgado JC, Genzen JR (2020). Modification of In Vitro Diagnostic Devices: Leveling the Playing Field. Clin Chem, 66(6), 760-762. (Read full article)
    15. Turner KA, Frinack JL, Ettore MW, Tate JR, Graziani MS, Jacobs JFM, Booth RA, McCudden CR, Keren DF, Delgado JC, Zemtsovskaja G, Fullinfaw RO, Caldini A, de Malmanche T, Katakouzinos K, Burke M, Palladini G, Altinier S, Zaninotto M, Righetti G, Melki MT, Bell S, Willrich MAV (2019). An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis. Clin Chem Lab Med, 58(4), 533-546. (Read full article)
    16. Jacobs JFM, Turner KA, Graziani MS, Frinack JL, Ettore MW, Tate JR, Booth RA, McCudden CR, Keren DF, Delgado JC, Zemtsovskaja G, Fullinfaw RO, Caldini A, de Malmanche T, Katakouzinos K, Burke M, Palladini G, Altinier S, Zaninotto M, Righetti G, Melki MT, Bell S, Willrich MAV (2019). An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins. Clin Chem Lab Med, 58(4), 547-559. (Read full article)
    17. Pavlov IY, Parker RL, Lzr-Molnr E, Strathmann FG, Delgado JC (2019). Inductively coupled plasma mass spectrometry assay for quantification of free infliximab in serum. J Immunol Methods, 470, 33-39. (Read full article)
    18. Ravkov EV, Charlton CM, Barker AP, Hill H, Peterson LK, Slev P, Tebo A, Voelkerding KV, Wittwer CT, Heikal N, Delgado JC, Lzr-Molnr E, Kumnovics A (2019). Evaluation of Mass Cytometry in the Clinical Laboratory. Cytometry B Clin Cytom, 96(4), 266-274. (Read full article)
    19. Delgado JC (2018). Value of Urinary Free Light Chain Testing for Monitoring of Bence Jones Proteinuria. J Appl Lab Med, 3(6), 1059-1060. (Read full article)
    20. Lzr-Molnr E, Delgado JC (2018). Implications of Monoclonal Antibody Therapeutics Use for Clinical Laboratory Testing. Clin Chem, 65(3), 393-405. (Read full article)
    21. Willrich MAV, Lazar-Molnar E, Snyder MR, Delgado JC (2017). Comparison of Clinical Laboratory Assays for Measuring Serum Infliximab and Antibodies to Infliximab. J Appl Lab Med, 2(6), 893-903. (Read full article)
    22. Genzen JR, Murray DL, Abel G, Meng QH, Baltaro RJ, Rhoads DD, Delgado JC, Souers RJ, Bashleben C, Keren DF, Ansari MQ (2018). Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice. Arch Pathol Lab Med, 142(4), 507-515. (Read full article)
    23. Thoren KL, Pasi B, Delgado JC, Wu AHB, Lynch KL (2017). Quantitation of Infliximab and Detection of Antidrug Antibodies in Serum by Use of Surface Plasmon Resonance. J Appl Lab Med, 2(5), 725-736. (Read full article)
    24. Profaizer T, Lazar-Molnar E, Pole A, Delgado JC, Kumanovics A (2017). HLA genotyping using the Illumina HLA TruSight next-generation sequencing kits: A comparison. Int J Immunogenet, 44(4), 164-168. (Read full article)
    25. Chiaro TR, Soto R, Zac Stephens W, Kubinak JL, Petersen C, Gogokhia L, Bell R, Delgado JC, Cox J, Voth W, Brown J, Stillman DJ, OConnell RM, Tebo AE, Round JL (2017). A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci Transl Med, 9(380). (Read full article)
    26. Zhou Z, Reyes-Vargas E, Escobar H, Chang KY, Barker AP, Rockwood AL, Delgado JC, He X, Jensen PE (2017). Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing. Eur J Immunol, 47(2), 314-326. (Read full article)
    27. Lzr-Molnr E, Delgado JC (2016). Immunogenicity Assessment of Tumor Necrosis Factor Antagonists in the Clinical Laboratory. Clin Chem, 62(9), 1186-98. (Read full article)
    28. Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J, Utah Transplant Affiliated Hospitals UTAH Cardiac Transplant Program (2016). Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. J Heart Lung Transplant, 35(8), 1024-30. (Read full article)
    29. Profaizer T, Lazar-Molnar E, Close DW, Delgado JC, Kumanovics A (2016). HLA genotyping in the clinical laboratory: comparison of next-generation sequencing methods. HLA, 88(1-2), 14-24. (Read full article)
    30. Zhou Z, Reyes-Vargas E, Escobar H, Rudd B, Rockwood AL, Delgado JC, He X, Jensen PE (2016). Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides. Eur J Immunol, 46(4), 834-45. (Read full article)
    31. Ware AL, Malmberg E, Delgado JC, Hammond ME, Miller DV, Stehlik J, Kfoury A, Revelo MP, Eckhauser A, Everitt MD (2016). The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children. J Heart Lung Transplant, 35(2), 179-85. (Read full article)
    32. Pavlov IY, Carper J, Lazar-Molnar E, Delgado JC (2016). Clinical laboratory application of a reporter-gene assay for measurement of functional activity and neutralizing antibody response to infliximab. Clin Chim Acta, 453, 147-53. (Read full article)
    33. Profaizer T, Coonrod EM, Delgado JC, Kumanovics A (2015). Report on the effects of fragment size, indexing, and read length on HLA sequencing on the Illumina MiSeq. Hum Immunol, 76(12), 897-902. (Read full article)
    34. Acevedo-Senz L, Carmona-Prez L, Velilla-Hernndez PA, Delgado JC, Rugeles L MT (2015). The APPEESFRS Peptide, Restricted by the HLA-B*35:01 Molecule, and the APPEESFRF Variant Derived from an Autologous HIV-1 Strain Induces Polyfunctional Responses in CD8+ T Cells. Biores Open Access, 4(1), 115-20. (Read full article)
    35. Chen L, Reyes-Vargas E, Dai H, Escobar H, Rudd B, Fairbanks J, Ho A, Cusick MF, Kumnovics A, Delgado J, He X, Jensen PE (2014). Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity. J Immunol, 193(3), 1427-39. (Read full article)
    36. Vonderheid EC, Pavlov I, Delgado JC, Martins TB, Telang GH, Hess AD, Kadin ME (2014). Prognostic factors and risk stratification in early mycosis fungoides. Leuk Lymphoma, 55(1), 44-50. (Read full article)
    37. Ravkov EV, Pavlov IY, Martins TB, Gleich GJ, Wagner LA, Hill HR, Delgado JC (2013). Identification and validation of shrimp-tropomyosin specific CD4 T cell epitopes. Hum Immunol, 74(12), 1542-9. (Read full article)
    38. Kanaseki T, Lind KC, Escobar H, Nagarajan N, Reyes-Vargas E, Rudd B, Rockwood AL, Van Kaer L, Sato N, Delgado JC, Shastri N (2013). ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. J Immunol, 191(4), 1547-55. (Read full article)
    39. Pavlov IY, Delgado JC (2013). Resampling model of the complement component functional assay: Are we measuring what we think we are measuring? Clin Chim Acta, 421, 87-90. (Read full article)
    40. Cronin K, Escobar H, Szekeres K, Reyes-Vargas E, Rockwood AL, Lloyd MC, Delgado JC, Blanck G (2013). Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors. Hum Vaccin Immunother, 9(4), 784-9. (Read full article)
    41. Heikal NM, Bader FM, Martins TB, Pavlov IY, Wilson AR, Barakat M, Stehlik J, Kfoury AG, Gilbert EM, Delgado JC, Hill HR (2013). Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy. Transplant Proc, 45(1), 376-82. (Read full article)
    42. Pavlov IY, Wilson AR, Delgado JC (2012). Reference interval computation: which method (not) to choose? Clin Chim Acta, 413(13-14), 1107-14. (Read full article)
    43. Taborda NA, Catao JC, Delgado JC, Rugeles MT, Montoya CJ (2012). Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers. J Acquir Immune Defic Syndr, 60(1), 12-9. (Read full article)
    44. Welch RJ, Merrigan SD, Delgado JC (2012). A spectrophotometric method to precisely determine endpoint titers in complement fixation assays. J Clin Lab Anal, 26(3), 190-3. (Read full article)
    45. Cho HI, Reyes-Vargas E, Delgado JC, Celis E (2012). A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy. Cancer Res, 72(8), 1986-95. (Read full article)
    46. Wang S, Delgado JC, Ravkov E, Eckels DD, Georgelas A, Pavlov IY, Cusick M, Sebastian K, Gleich GJ, Wagner LA (2012). Penaeus monodon tropomyosin induces CD4 T-cell proliferation in shrimp-allergic patients. Hum Immunol, 73(4), 426-31. (Read full article)
    47. Kadin ME, Pavlov IY, Delgado JC, Vonderheid EC (2012). High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides. J Invest Dermatol, 132(3 Pt 1), 703-10. (Read full article)
    48. Ravkov EV, Pavlov IY, Hanson KE, Delgado JC (2012). Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant. Clin Dev Immunol, 2012, 451059. (Read full article)
    49. Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, Delgado JC, Welsh RM, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rock KL (2011). Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol, 13(2), 129-35. (Read full article)
    50. Profaizer T, Eckels D, Delgado JC (2011). Celiac disease and HLA typing using real-time PCR with melting curve analysis. Tissue Antigens, 78(1), 31-7. (Read full article)
    51. Escobar H, Reyes-Vargas E, Jensen PE, Delgado JC, Crockett DK (2011). Utility of characteristic QTOF MS/MS fragmentation for MHC class I peptides. J Proteome Res, 10(5), 2494-507. (Read full article)
    52. Pavlov IY, De Forest N, Delgado JC (2011). Specificity of EIA immunoassay for complement factor Bb testing. Clin Lab, 57(3-4), 225-8. (Read full article)
    53. Pavlov IY, Shihab F, Delgado JC (2011). Urine TGF- beta1 assay validation: spinning down urine samples could diminish TGF-beta1 signal. Clin Lab, 57(11-12), 1027-9. (Read full article)
    54. Pavlov IY, Wilson AR, Delgado JC (2010). Resampling approach for determination of the method for reference interval calculation in clinical laboratory practice. Clin Vaccine Immunol, 17(8), 1217-22. (Read full article)
    55. Blanchard N, Kanaseki T, Escobar H, Delebecque F, Nagarajan NA, Reyes-Vargas E, Crockett DK, Raulet DH, Delgado JC, Shastri N (2010). Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J Immunol, 184(6), 3033-42. (Read full article)
    56. Delgado JC, Pavlov IY, Shihab FS (2009). Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study. Transpl Immunol, 22(1-2), 1-4. (Read full article)
    57. Stehlik J, Islam N, Hurst D, Kfoury AG, Movsesian MA, Fuller A, Delgado JC, Hammond ME, Gilbert EM, Renlund DG, Bader F, Fisher PW, Bull DA, Singhal AK, Eckels DD (2009). Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant, 28(11), 1129-34. (Read full article)
    58. Chen LC, Delgado JC, Jensen PE, Chen X (2009). Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application. J Immunol, 183(6), 4094-102. (Read full article)
    59. Pavlov I, Martins TB, Delgado JC (2009). Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing. Clin Vaccine Immunol, 16(9), 1327-31. (Read full article)
    60. Delgado JC, Escobar H, Crockett DK, Reyes-Vargas E, Jensen PE (2009). Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction. Immunogenetics, 61(3), 241-6. (Read full article)
    61. Gundlapalli AV, Delgado JC, Jackson BR, Tricot GJ, Hill HR (2009). Composite patient reports: a laboratory informatics perspective and pilot project for personalized medicine and translational research. Summit Transl Bioinform, 2009, 39-43. (Read full article)
    62. Delgado JC, Fuller A, Ozawa M, Smith L, Terasaki PI, Shihab FS, Eckels DD (2009). No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study. Transplantation, 87(4), 546-8. (Read full article)
    63. Reyes-Vargas E, Pavlov IY, Martins TB, Schwartz JJ, Hill HR, Delgado JC (2009). Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern. J Clin Lab Anal, 23(3), 157-60. (Read full article)
    64. Escobar H, Crockett DK, Reyes-Vargas E, Baena A, Rockwood AL, Jensen PE, Delgado JC (2008). Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs. J Immunol, 181(7), 4874-82. (Read full article)
    65. Delgado JC, Eckels DD (2008). Positive B-cell only flow cytometric crossmatch: implications for renal transplantation. Exp Mol Pathol, 85(1), 59-63. (Read full article)
    66. Bedoya VI, Jaimes FA, Delgado JC, Rugeles C, Usuga X, Zapata W, Castao ME, Boasso A, Shearer G, Rugeles MT (2008). Fetal-maternal HLA-A and -B discordance is associated with placental RNase expression and anti-HIV-1 activity. Curr HIV Res, 6(4), 380-7. (Read full article)
    67. Husain Z, Almeciga I, Delgado JC, Clavijo OP, Castro JE, Belalcazar V, Pinto C, Zuniga J, Romero V, Yunis EJ (2006). Increased FasL expression correlates with apoptotic changes in granulocytes cultured with oxidized clozapine. Toxicol Appl Pharmacol, 214(3), 326-34. (Read full article)
    68. Delgado JC, Baena A, Thim S, Goldfeld AE (2006). Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia. J Immunol, 176(2), 1090-7. (Read full article)
    69. Thim S, Sath S, Sina M, Tsai EY, Delgado JC, Shapiro AE, Barry CE 3rd, Glaziou P, Goldfeld AE (2004). A community-based tuberculosis program in Cambodia. JAMA, 292(5), 566-8. (Read full article)
    70. Delgado JC, Quinones-Berrocal J, Thim S, Miranda LF, Goldfeld AE (2004). Diagnostic and clinical implications of response to tuberculin in two ethnically distinct populations from Peru and Cambodia. Int J Tuberc Lung Dis, 8(8), 982-7. (Read full article)
    71. Delgado JC, Leung JY, Baena A, Clavijo OP, Vittinghoff E, Buchbinder S, Wolinsky S, Addo M, Walker BD, Yunis EJ, Goldfeld AE (2003). The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia. Immunogenetics, 55(7), 497-501. (Read full article)
    72. Baena A, Leung JY, Sullivan AD, Landires I, Vasquez-Luna N, Quinones-Berrocal J, Fraser PA, Uko GP, Delgado JC, Clavijo OP, Thim S, Meshnick SR, Nyirenda T, Yunis EJ, Goldfeld AE (2002). TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun, 3(8), 482-7. (Read full article)
    73. Delgado JC, Baena A, Thim S, Goldfeld AE (2002). Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis, 186(10), 1463-8. (Read full article)
    74. Delgado JC, Tsai EY, Thim S, Baena A, Boussiotis VA, Reynes JM, Sath S, Grosjean P, Yunis EJ, Goldfeld AE (2002). Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci U S A, 99(11), 7576-81. (Read full article)
    75. Delgado JC, Loughlin KR, Bosch RJ, Tanasijevic MJ (2002). Comparison of the Tandem-E Immunoenzymetric and Immuno-1 PSA assays. Lab Med, (33), 208-11.
    76. Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, Uglialoro AM, Clavijo OP, Rosenberg ES, Kalams SA, Braun JD, Boswell SL, Walker BD, Goldfeld AE (2001). Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A, 98(9), 5140-5. (Read full article)
    77. Delgado JC, Shulman LN, Gudrais P, Fischer GA, Fergurson DO, Winkelman JW, Tanasijevic MJ (2001). Standardization of CEA testing in the setting of clinical laboratory consolidation. Lab Med, (32), 92-5.
    78. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE (2000). IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest, 105(9), 1317-25. (Read full article)
    79. Delgado JC, Greene MF, Winkelman JW, Tanasijevic MJ (2000). Comparison of disaturated phosphatidylcholine and fetal lung maturity surfactant/albumin ratio in diabetic and nondiabetic pregnancies. Am J Clin Pathol, 113(2), 233-9. (Read full article)
    80. Clavijo OP, Delgado JC, Yu N, Fraser PA, Yunis EJ (1999). HLA-Cw*1701 is associated with two sub-Saharan African-derived HLA haplotypes: HLA-B*4201, DRB1*03 and HLA-B*4202 without DRB1*03. Tissue Antigens, 54(3), 303-6. (Read full article)
    81. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfeld AE (1998). Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens, 52(4), 359-67. (Read full article)
    82. Clavijo OP, Delgado JC, Awdeh ZL, Fici D, Turbay D, Alper CA, Truedsson L, Yunis EJ (1998). HLA-Cw alleles associated with HLA extended haplotypes and C2 deficiency. Tissue Antigens, 52(3), 282-5. (Read full article)
    83. Weinreb S, Delgado JC, Clavijo OP, Yunis EJ, Bayer-Zwirello L, Polansky L, Deluhery L, Cohn G, Yao JT, Stec TC, Higby D, Anderzejewski C (1998). Transplantation of unrelated cord blood cells. Bone Marrow Transplant, 22(2), 193-6. (Read full article)
    84. Goldfeld AE, Delgado JC, Thim S, Bozon MV, Uglialoro AM, Turbay D, Cohen C, Yunis EJ (1998). Association of an HLA-DQ allele with clinical tuberculosis. JAMA, 279(3), 226-8. (Read full article)
    85. Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, Daley J, Delgado JC, Gribben JG, Nadler LM (1997). CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest, 100(11), 2757-65. (Read full article)
    86. Delgado JC, Hameed A, Yunis JJ, Bhol K, Rojas AI, Rehman SB, Khan AA, Ahmad M, Alper CA, Ahmed AR, Yunis EJ (1997). Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients. Hum Immunol, 57(2), 110-9. (Read full article)
    87. Bozn MV, Delgado JC, Selvakumar A, Clavijo OP, Salazar M, Ohashi M, Alosco SM, Russell J, Yu N, Dupont B, Yunis EJ (1997). Error rate for HLA-B antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods. Tissue Antigens, 50(4), 387-94. (Read full article)
    88. Mobini N, Yunis EJ, Alper CA, Yunis JJ, Delgado JC, Yunis DE, Firooz A, Dowlati Y, Bahar K, Gregersen PK, Ahmed AR (1997). Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin. Hum Immunol, 57(1), 62-7. (Read full article)
    89. Turbay D, Lieberman J, Alper CA, Delgado JC, Corzo D, Yunis JJ, Yunis EJ (1997). Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups. Blood, 89(11), 4167-74. (Read full article)
    90. Delgado JC, Yunis DE, Bozn MV, Salazar M, Deulofeut R, Turbay D, Mehra NK, Pasricha JS, Raval RS, Patel H, Shah BK, Bhol K, Alper CA, Ahmed AR, Yunis EJ (1996). MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India. Tissue Antigens, 48(6), 668-72. (Read full article)
    91. Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, Norman R, Alper CA, Good RA, Ahmed R (1996). A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A, 93(16), 8569-71. (Read full article)
    92. Bozn MV, Delgado JC, Turbay D, Salazar M, Granja CB, Alosco SM, Dupont B, Yunis EJ (1996). Comparison of HLA-A antigen typing by serology with two polymerase chain reaction based DNA typing methods: implications for proficiency testing. Tissue Antigens, 47(6), 512-8. (Read full article)

    Book Chapter

    1. Lazar-Molnar E, Willrich MAV, Delgado JC (2022). Monoclonal Antibody Therapeutics and Immunogenicity. In Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT (Eds.), Tietz Textbook of Laboratory Medicine (7th). Elsevier.
    2. Genzen JR, Peake R, Tate J, Delgado JC, Miller S (2017). Tietz Atlas of Electrophoretic Patterns. In Rifai N, Horvath AR, Wittwer CT (Eds.), Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (6th Edition). St. Louis, MO: Elsevier.
    3. Kumanovics A, Delgado JC (2016). The Major Histocompatibility Complex and Disease. In McPerson RA, Pincus MR (Eds.), Henry's Clinical Diagnosis and Management by Laboratory Methods (23rd, pp. 973-982). Philadelphia: Elsevier.
    4. Delgado JC (2011). The Major Histocompatibility Complex and Disease. In McPherson RA; Pincus MR (Ed.), Henry's Clinical Diagnosis and Management by Laboratory Methods (22nd, pp. 954-962). Philadelphia: Elsevier Saunders.
    5. Delgado JC, Yunis EJ (2007). The Major Histocompatibility Complex and Disease. In McPherson RA; Pincus MR (Ed.), Henry's Clinical Diagnosis and Management by Laboratory Methods (pp. 894-905). Philadelphia: Saunders Elsevier.
    6. Delgado JC, Yunis EJ (2001). The Major Histocompatibility Complex and Disease. In Henry JB (Ed.), Henry's Clinical Diagnosis and Management by Laboratory Methods (pp. 949-62). Philadelphia: W.B Saunders.
    7. Delgado JC, Sese DE, Milford EL, Yunis EJ (2001). Analysis of HLA class II DRB1 alleles using PCR-RFLP. In American Society for Histocompatibility Technical Manual.
    8. Hors J, ElChenawi F, Djoulah S, Hafez M, Abbas F, ElBorai MH, Kamel M, Abbal M, Cambon-Thomsen A, Mercier P, Reviron D, Magzoub MA, Rosner G, Delgado JC, Yunis EJ, Raffoux C, Tamouza R, Izaabel H, Hmida S, Benhamamouch S, Bessaoud K, Langaney A, Sanchez-Mazas A (1998). HLA in North African populations: 12th International Histocompatibility Workshop NAFR report. In Charron D (Ed.), HLA Genetic diversity of HLA functional and medical implication (pp. 328-34). Paris: EDK International Publisher.

    Commentary

    1. Delgado JC, Jensen PE (2008). Cat and mouse. Nat Immunol, 9(8), 829-30. (Read full article)
    2. Delgado JC, Jensen PE (2007). Trimming creates a new self-image. Nat Immunol, 8(1), 21-2. (Read full article)

    Editorial

    1. Delgado JC, Lzr-Molnr E (2018). HLA in Transplantation and Beyond. Clin Lab Med, 38(4), xi-xii. (Read full article)

    Other

    1. Delgado JC, Yunis EJ (1997). Stem Cell transplatation: Medical and technical aspects. American Association of Blood Banks, 50th Anniversary Syllabus.

    Video/Film/CD/Web/Podcast

    1. Delgado JC (2015). Spotlight on Testing: High-Resolution HLA Genotyping by Next-Generation Sequencing [Web]. Salt Lake City: University of Utah Department of Pathology, and ARUP Laboratories. Available: http://arup.utah.edu/education/shortTopics/spot_HLA.php.
    2. Delgado JC (2014). Spotlight on Testing: Test-Guided Management of Treatment Failure to TNF-alpha Antagonists [Web]. Salt Lake City: University of Utah Department of Pathology, and ARUP Laboratories. Available: http://arup.utah.edu/education/shortTopics/spot_TNFalpha.php.